PMID: 9460332Feb 14, 1998Paper

Psoralen photochemotherapy

Dermatology Nursing
P B McClellandJ Shelk

Abstract

Psoralens and sunlight have been used by the Egyptians and Indians for hundreds of years for treating vitiligo. The combination of oral psoralens and artificial ultraviolet A (PUVA) therapy was approved for managing severe psoriasis by the Food and Drug Administration in 1982. Since then, PUVA therapy has been an effective modality for treating many cutaneous conditions (psoriasis, atopic dermatitis, vitiligo, and mycosis fungoides). However, proper knowledge and administration of PUVA therapy are vital to treatment success and reducing side effects.

Related Concepts

Education, Nursing, Continuing
Ficusin
Photochemotherapy
Dermatologic Disorders
Ultraviolet Therapy
Photosensitizing Effect

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

Journal of the American Academy of Dermatology
A K Gupta, T F Anderson
Photodermatology, Photoimmunology & Photomedicine
Sharam Samson YasharHenry W Lim
© 2021 Meta ULC. All rights reserved